GROLLEAU SACA (ALGRO.PA) Fundamental Analysis & Valuation

EPA:ALGRO • FR0014005ZM5

Current stock price

2.88 EUR
+0.24 (+9.09%)
Last:

This ALGRO.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALGRO.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALGRO has reported negative net income.
  • In the past year ALGRO had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALGRO reported negative net income in multiple years.
  • In the past 5 years ALGRO always reported a positive cash flow from operatings.
ALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFALGRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 1M -1M 2M -2M -3M

1.2 Ratios

Industry RankSector Rank
ROA -4.77%
ROE -13.65%
ROIC N/A
ROA(3y)-0.82%
ROA(5y)0.31%
ROE(3y)-2.62%
ROE(5y)-0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALGRO.PA Yearly ROA, ROE, ROICALGRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • ALGRO's Gross Margin has declined in the last couple of years.
  • ALGRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5YN/A
ALGRO.PA Yearly Profit, Operating, Gross MarginsALGRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

2

2. ALGRO.PA Health Analysis

2.1 Basic Checks

  • ALGRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALGRO has about the same amount of shares outstanding.
  • The debt/assets ratio for ALGRO has been reduced compared to a year ago.
ALGRO.PA Yearly Shares OutstandingALGRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALGRO.PA Yearly Total Debt VS Total AssetsALGRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of 1.80, we must say that ALGRO is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.45 indicates that ALGRO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.8
ROIC/WACCN/A
WACC6.67%
ALGRO.PA Yearly LT Debt VS Equity VS FCFALGRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • ALGRO has a Current Ratio of 1.42. This is a normal value and indicates that ALGRO is financially healthy and should not expect problems in meeting its short term obligations.
  • ALGRO has a Quick Ratio of 1.42. This is a bad value and indicates that ALGRO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.98
ALGRO.PA Yearly Current Assets VS Current LiabilitesALGRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. ALGRO.PA Growth Analysis

3.1 Past

  • The earnings per share for ALGRO have decreased strongly by -17827.59% in the last year.
  • Looking at the last year, ALGRO shows a quite strong growth in Revenue. The Revenue has grown by 17.09% in the last year.
  • ALGRO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.30% yearly.
EPS 1Y (TTM)-17827.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-249.96%
Revenue 1Y (TTM)17.09%
Revenue growth 3Y21.3%
Revenue growth 5YN/A
Sales Q2Q%-15.3%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.23% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 7.39% on average over the next years.
EPS Next Y-66.67%
EPS Next 2Y52.75%
EPS Next 3Y44.23%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y8.17%
Revenue Next 3Y7.39%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALGRO.PA Yearly Revenue VS EstimatesALGRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALGRO.PA Yearly EPS VS EstimatesALGRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

1

4. ALGRO.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALGRO. In the last year negative earnings were reported.
  • ALGRO is valuated quite expensively with a Price/Forward Earnings ratio of 27.96.
  • ALGRO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.50.
Industry RankSector Rank
PE N/A
Fwd PE 27.96
ALGRO.PA Price Earnings VS Forward Price EarningsALGRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.24
ALGRO.PA Per share dataALGRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • ALGRO's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.75%
EPS Next 3Y44.23%

0

5. ALGRO.PA Dividend Analysis

5.1 Amount

  • No dividends for ALGRO!.
Industry RankSector Rank
Dividend Yield 0%

ALGRO.PA Fundamentals: All Metrics, Ratios and Statistics

GROLLEAU SACA

EPA:ALGRO (4/17/2026, 7:00:00 PM)

2.88

+0.24 (+9.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.41%
Inst Owner ChangeN/A
Ins Owners14.07%
Ins Owner ChangeN/A
Market Cap8.18M
Revenue(TTM)39.88M
Net Income(TTM)-1.46M
Analysts86.67
Price Target5.61 (94.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.96
P/S 0.21
P/FCF N/A
P/OCF 6.7
P/B 0.76
P/tB 1.06
EV/EBITDA 10.24
EPS(TTM)-0.51
EYN/A
EPS(NY)0.1
Fwd EY3.58%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.43
OCFY14.92%
SpS14.04
BVpS3.77
TBVpS2.71
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.77%
ROE -13.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.31%
FCFM N/A
ROA(3y)-0.82%
ROA(5y)0.31%
ROE(3y)-2.62%
ROE(5y)-0.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.61%
GM growth 5YN/A
F-Score5
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 5.02
Cap/Depr 75.83%
Cap/Sales 3.19%
Interest Coverage N/A
Cash Conversion 126.95%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 0.98
Altman-Z 1.8
F-Score5
WACC6.67%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.09%
Cap/Sales(5y)5.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17827.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-249.96%
EPS Next Y-66.67%
EPS Next 2Y52.75%
EPS Next 3Y44.23%
EPS Next 5YN/A
Revenue 1Y (TTM)17.09%
Revenue growth 3Y21.3%
Revenue growth 5YN/A
Sales Q2Q%-15.3%
Revenue Next Year0%
Revenue Next 2Y8.17%
Revenue Next 3Y7.39%
Revenue Next 5YN/A
EBIT growth 1Y-2048.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year560.19%
EBIT Next 3Y162.07%
EBIT Next 5YN/A
FCF growth 1Y94.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.02%
OCF growth 3Y43.51%
OCF growth 5YN/A

GROLLEAU SACA / ALGRO.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GROLLEAU SACA?

ChartMill assigns a fundamental rating of 2 / 10 to ALGRO.PA.


What is the valuation status of GROLLEAU SACA (ALGRO.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to GROLLEAU SACA (ALGRO.PA). This can be considered as Overvalued.


What is the profitability of ALGRO stock?

GROLLEAU SACA (ALGRO.PA) has a profitability rating of 1 / 10.


What is the expected EPS growth for GROLLEAU SACA (ALGRO.PA) stock?

The Earnings per Share (EPS) of GROLLEAU SACA (ALGRO.PA) is expected to decline by -66.67% in the next year.